For U.S. beauty brands, importers, distributors and e-commerce sellers sourcing from China, the practical brief connects the product route, samples, packaging, MOQ and replenishment plan with U.S. label, MoCRA and import responsibilities. UniBeauty coordinates product development and supply; it is not a U.S. manufacturer, FDA agent or legal adviser.
Updated September 2026 · Internal review owner: UniBeauty Product & Compliance Coordination
Start with the product, quantity per SKU, launch date and U.S. sales channel—then choose ready stock, simple private label, OEM or ODM. A new brand that still needs to validate demand may be better served by confirmed stock or an eligible unbranded formula. A project that needs exclusive shades, formula changes, custom components or full packaging development requires a larger production commitment and a longer approval path.
At the same time, identify the U.S. responsible person, importer and regulatory reviewer. Product listing, facility registration, safety substantiation, label review and import entry are separate responsibilities; a factory quotation alone does not complete the U.S. market-entry plan.
Buyers often search for a low-MOQ private label cosmetics manufacturer, ready-to-label cosmetics, custom formulation or contract manufacturing as if they were the same service. The practical differences are inventory status, ownership of the product brief, packaging method, production setup and quantity.
Use confirmed inventory to test products and channels before carrying a full custom production run. UniBeauty can organize a shortlist with SKU, shade or version, indicative stock, sample status, packaging status and whether the item is unbranded, already branded or potentially eligible for co-branding. Availability and dispatch timing are reconfirmed before order.
For some established, unbranded skincare products, approximately 500–1,000 units may be possible when the work is mainly a customer label and redesigned outer carton. Formula, packaging, artwork, claims, U.S. label inputs and quantity per SKU still require review. This is a conditional route, not a universal low MOQ.
Custom private-label makeup generally starts around 5,000–10,000 units because shade production, filling, component purchase and logo decoration must reach workable batches. The same logo can involve screen printing, hot stamping, labels or other processes, each with different setup, component MOQ, unit cost and lead time.
OEM/ODM projects from several thousand to tens of thousands can support broader formula, component and packaging development. Exact price and timing depend on the product brief, formula route, testing, component, decoration, pack versions and documents. A larger quantity can reduce unit cost, but only when the buyer can sell and replenish that inventory.
Portfolio recommendation: build several long-term core SKUs with repeat-purchase potential, then use a controlled number of new or trend-led items to create attention. “New” does not automatically mean a large or durable market; reachable audience, acquisition cost, margin, repeat purchase and replenishment determine commercial value.
State whether the product is for DTC, Amazon, retail, spa/salon, wholesale or distribution. Define the product’s cosmetic purpose and proposed claims early; claims to treat or prevent disease or affect body structure or function may cause a product to be regulated as a drug.
Share the product format, benchmark, number of shades or variants, target pack, first-order quantity and repeat-order expectation. Packaging or printing MOQ can be higher than the formula or filling minimum, so a multi-SKU total is not automatically the usable quantity for each item.
Map the final formula code and ingredient declaration to the intended U.S. use. For color cosmetics, confirm that color additives are permitted for the intended application and determine whether batch certification requirements apply.
Evaluate product performance, shade or scent, fill, formula–component compatibility, logo method, carton and label copy. Record the approved formula, sample, component and artwork version before production begins.
Identify the responsible person named on the label, the regulatory reviewer, the facility-registration and U.S.-agent contacts where applicable, and who will maintain product listings, safety-substantiation records and adverse-event procedures.
Align the declared manufacturer, importer/consignee, product description, country of origin, shipping documents and broker instructions. Keep a repeat-order file for the final formula, label, pack, quantity, inspection requirements and approved changes.
MoCRA responsibilities depend on the actual company, facility, product and any applicable exemption. The buyer should verify its responsibility map with current FDA materials and qualified U.S. professionals.
| Workstream | Current FDA planning point | Project question |
|---|---|---|
| Facility registration | Manufacturers and processors subject to the requirement register the facility and renew every two years. FDA uses an FEI as the facility registration number. | Which actual manufacturing or processing facility applies to the final product? |
| Foreign-facility U.S. agent | FDA’s registration guidance requires a U.S. agent for a foreign facility’s registration. | Who is authorized to act as the facility’s U.S. agent for this purpose? |
| Cosmetic product listing | The responsible person—the manufacturer, packer or distributor whose name appears on the label—lists each marketed cosmetic product with ingredients and provides updates annually. | Which company is the responsible person, and who will submit and maintain the listing? |
| Safety substantiation | The responsible person must ensure and maintain records supporting adequate safety substantiation. FDA does not prescribe one test for every cosmetic. | Which existing data and product-specific evaluations support the final formula and intended use? |
| Serious adverse events | The responsible person reports a serious adverse event associated with U.S. use to FDA within 15 business days and maintains the related process. | What consumer contact and escalation procedure will operate after launch? |
| Exemption review | MoCRA includes certain small-business exemptions, with exclusions for specified product types. An exemption should be confirmed for the actual business and product. | Has a qualified reviewer documented whether an exemption applies? |
Do not market registration as approval: FDA states that facility registration and cosmetic product listing are not a cosmetic approval program, and it does not issue certificates proving compliance for those submissions. A registration or listing number does not mean that FDA approved the facility or cosmetic product.
| Label input | Planning point | Buyer confirmation |
|---|---|---|
| Identity statement | State what the cosmetic is on the principal display panel. | Does the product identity match its intended cosmetic use and product listing? |
| Name and place of business | Use the manufacturer, packer or distributor name and place of business with appropriate qualifying wording when the named company is not the manufacturer. | Which company will appear, and is it the MoCRA responsible person? |
| Net quantity | Prepare the net-quantity statement for the principal display panel in the applicable U.S. format. | Does it match the approved fill and component? |
| Ingredient declaration | Keep the ingredient declaration aligned with the final approved formula and applicable naming and placement rules. | Which final formula code and shade family does the artwork represent? |
| Warnings and directions | Include any required warnings and directions needed for safe use based on the product and ingredients. | Have intended use, restricted ingredients and product-specific cautions been reviewed? |
| Country of origin | Imported products must state the English name of the country of origin. | Is the origin statement accurate for the finished product? |
| Marketing claims | Claims must be truthful and not misleading. Disease-treatment or body structure/function claims can change the regulatory category. | Has the final pack, website and marketplace copy been reviewed together? |
A detailed brief lets UniBeauty recommend products by the buyer’s actual parameters and expected quantity instead of forcing every project into the same catalog or MOQ.
What UniBeauty returns: a project-specific route recommendation, available product or development options, sample path, packaging possibilities, conditional MOQ, quotation inputs, indicative schedule and agreed document list. Final feasibility, price, stock and lead time are confirmed against the selected product and configuration.
Compare makeup, skincare, tools, lashes and multi-category supply routes.
Review serums, creams, masks and the project-specific skincare route.
Plan face, eye and lip products, shades, components and decoration.
Understand who owns the brief, formula path and development work.
Connect the component, logo method, artwork, MOQ and pack approval.
Separate total order size from each formula, shade and packaging minimum.
Assign product, packaging and destination-market file responsibilities.
Align quotation scope, freight responsibilities and destination handoff.
These FDA primary sources were reviewed for this guide. Rules and agency guidance can change, so use the current official pages during formula, artwork, registration, listing and import planning.
Regulatory boundary: Information provided is for general reference only and should be verified with official authorities and qualified regulatory professionals. UniBeauty may coordinate available formula information, packaging inputs and agreed project documents, but it does not provide legal advice, act as the buyer’s responsible person or U.S. agent, submit filings on the buyer’s behalf, or guarantee FDA, CBP or marketplace acceptance.
Tell us what you want to sell, the U.S. channel, quantity per SKU, desired customization, pack concept and launch date. We will compare available stock, simple private label, custom private label, OEM and ODM routes before you commit to unnecessary development, printing or inventory.
Discuss a U.S. cosmetics project